An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health – helping European industry become more competitive in the growing biosensor device market. The devices can also be used for citizen science applications. Successful biosensors have to be versatile, small, easy to […]Continue Reading ...
Project – funded by Innovate UK and Medical Research Council Biomedical Catalyst 2018, Round 1 Competition – will see bioresorbable stents treating severe vascular disease and dissolving within two years after implant A £1.1 million project to develop biodegradable stents for patients with severe vascular disease, which affects around one million people in the UK, […]Continue Reading ...
The European Advanced infraStructure for Innovative Genomics (EASI-Genomics), a project funded under the European Union’s research and innovation programme Horizon 2020, will provide researchers free-of-charge access to cutting-edge European genomics facilities. EASI-Genomics joins 16 academic and industrial partners to support diverse genomics project from study design, over state-of-the-art sequencing to bioinformatic analysis. EASI-Genomics is an […]Continue Reading ...
Proteins are the basis of cellular and physiological functioning in living organisms. The physical and chemical properties of proteins determine how they act and work within cells. Therefore, the analysis of protein abnormalities is particularly important for the study of heart disease, neurodegenerative diseases, diabetes and cancer. The objective of the EU-funded BIOCAPTURE project is […]Continue Reading ...
Aurora Labs Limited (“Aurora” or “the Company”), is pleased to announce that it has signed a binding term sheet with the University of Western Australia (“UWA”) and Royal Perth Hospital (“RPH”) in a collaboration agreement to develop 3D printing of titanium medical implants (the “Project”). The objective of the Project is to develop designs, specifications […]Continue Reading ...
Lancaster University is sharing in a €4m project to use gaming technology to improve the care of both adults and children with cancer. The project – called “MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems” funded by EU Horizon 2020, has 16 partners in seven countries. It […]Continue Reading ...
A new EU project on the theme of HIV, hepatitis C and tuberculosis is a door opener for collaboration between researchers from EU countries and Russia. One of the project’s initiators is Anders Sönnerborg, Professor of Clinical Virology and Infectious Diseases at KI’s Departments of Laboratory Medicine, and Medicine Huddinge. The project Common Actions Against […]Continue Reading ...
Within the framework of a European collaborative research project, Oliver Müller, professor at the Faculty of Medicine at Kiel University (CAU) and Consultant at the Department of Internal Medicine III, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, will receive 1.4 million Euros for the project “CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease”. The […]Continue Reading ...
Apr 2 2019 Unitive Design & Analysis (UDA) are the sole UK contributors to a three year translational project to develop a prototype Point of Care Diagnostic tool to address the growing problem of Lyme disease. Lyme Borreliosis (LB) infections are caused by the spirochete bacteria, Borrelia burgdorferi, and are difficult to detect, leading to […]Continue Reading ...
Currently, the most advanced prosthetics on the market use technology that is more than four decades old. The challenge for today’s scientists and engineers is to develop a more dextrous prosthetic limb that can help amputees carry out more of the tasks that others take for granted. The EU-funded INPUT project focuses on improving the […]Continue Reading ...
A timely new project funded by the European Union (EU) will explore how to improve current testing tools for Endocrine Disrupting Chemicals (EDCs), particularly for chemicals that are less studied so far. Launched in January, the ERGO project aims to break down the wall between human health and environmental testing of endocrine disrupters and focuses […]Continue Reading ...
Porvair Sciences reports on its involvement in a new £2.6 million project led by Swansea University (UK) that aims to dramatically improve the diagnosis and treatment of ovarian cancer. This project will involve collaboration with 5 key industrial partners – Porvair Sciences, Bruker UK, GE Healthcare UK, Axis Bio and GlaxoSmithKline (GSK). A new Antibody […]Continue Reading ...
For a better understanding of biological processes, researchers need to be able to ‘see’ the smallest components of individual cells, such as DNA, mRNA and proteins. In response, the EU-funded CELLVIEWER project is developing a super-resolution microscope that uses hardware and software which enables the collection of high-resolution spatial and dynamic information in single cells. […]Continue Reading ...
Microbes offer an untapped potential and could be the key to a better and healthier living. Yet, research and innovation developments on microbiomes remain scarce. To challenge the state of play, the European Union has made the development of innovative applications on microbiomes a priority. Between 2018 and 2023, the EU is providing four consortia […]Continue Reading ...
The newly started European-funded project MicrobiomeSupport held its kick-off meeting on 28 November 2018 in Ottawa, Canada. The project is a Coordination and Support Action, running until October 2022, with a two-fold aim: Harmonizing the methods, approaches and standards used in microbiome research in different types of environment (soil, aquatic environments, animals, humans, etc.) and […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models